← Open Payments lookup

JENNIFER JAVA: Open Payments

NPI 1053046912 · ANAHEIM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,095 in 183 payments from 20 companies in 2025. Trend: 2023 $4,927 · 2024 $4,556 · 2025 $4,095

Food & beverage: $4,095
CompanyPaymentsAmount
ABBVIE INC.29$590
Neurocrine BioSciences, Inc.20$572
Alkermes, Inc.20$435
Otsuka America Pharmaceutical, Inc.16$433
Janssen Pharmaceuticals, Inc11$400
Teva Pharmaceuticals USA, Inc.14$337
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)15$255
E.R. Squibb & Sons, L.L.C.9$222
Lundbeck LLC10$209
Noven Therapeutics, LLC10$182

Products named: VRAYLAR, INGREZZA, REXULTI, ARISTADA, INVEGA SUSTENNA, AUSTEDO XR, CAPLYTA, COBENFY.

Industry payments across CA — which companies pay providers there.